Rosenberg equities

The language of a crisis

Alongside rigorous financial statement analysis, the detailed evaluation of text data has become an important part of Rosenberg Equities’ research and investment process. In this short update, Alex Ions, Head of Alternative Data Research, and Research Analyst Euan Mackay discuss what earnings transcripts and regulatory filings can tell us about companies’ and analysts’ reactions to the coronavirus outbreak.

As part of Rosenberg Equities’ analysis of text data, for the past two years we have announced an annual “Word of the Year”, using our proprietary natural language processing framework to identify what mattered most to managers and analysts based on the words they used in quarterly calls and regulatory filings.

While annual updates provide an interesting longer-term perspective, one of the strengths of our framework is the ability to run the numbers every day. This enables us to capture short-term shifts in sentiment and see market trends take shape on an almost real-time basis.

This more immediate perspective yields a clear picture of the most important topic so far this year: Covid-19. In line with the tragic spread of the coronavirus across the world in recent months, references to it – as well as to related terms, such as “pandemic” – have sharply increased. Analysing close to 5,000 earnings calls since the start of this year, we find that these “keywords” went from appearing in almost no meetings at the beginning of the quarter to featuring in essentially every management presentation by the end of March.

As the chart below shows, initial mentions of Covid-19 by management teams were largely related to its outbreak in China, but began to focus on the broader impact to global supply and demand as the quarter progressed. Similar patterns are also evident in the questions analysts posed to managers and in companies’ regulatory filings, where the crisis has come to dominate disclosures in recent weeks as executives sought to inform investors about interruptions to their operations.

From information to insight

The language that managers and analysts use can tell us much about the sentiment around individual stocks and the market as a whole.

For example, raw ‘language sentiment’ scores can give us an insight into managements’ confidence at a given point in time. They can also alert us to how analysts are responding to their strategies.

Beyond this, by evaluating how the language  in analyst meetings and corporate filings has evolved over time we gain a sense of the trajectory of sentiment around a company, complementing what we see in other data sets, such as price momentum, media coverage and analysts’ earnings revisions. Aggregating this data can reveal a big-picture view of the direction of sentiment in the economy.                       

Unsurprisingly, the latest shift in sentiment has been decidedly negative. As the charts below show, companies’ presentations on earnings calls have become increasingly pessimistic since the start of March and the tenor of analyst questions has turned similarly negative, although the latest data suggest some improvement.

Clearly, this is a short-term view of a highly complex and extremely fast-moving crisis. These conditions create challenges to detailed analysis that must be carefully managed. We must also recognise that the data suggest most managers and analysts were late to recognise the severity of the coronavirus and its likely business impact. (Notice that the spike in negative sentiment shown in the charts came only after the WHO’s official declaration of a pandemic on March 11.)

Conclusion

As the collective understanding of the virus improves, company statements and analyst questions should reflect this, providing more nuanced information around the risks and opportunities faced by individual firms and how they are approaching them. This could increase the quality of insights we can glean from the analysis.

In time, we also hope to see other signs in the data. Most notably, as the global response to the coronavirus gains traction, we look forward to seeing references to our keywords stabilize and eventually fall and the tone of the references start to improve. These would be early markers that the world is beginning to recover from this crisis.

Change in sentiment, 1-week moving average*

* Source of all data is Rosenberg Equities, as of 1 April 2020, based on our global investment universe. Change in sentiment for each meeting is measured relative to the corresponding company meeting in 2019. Chart shows average sentiment across all companies having meetings in a 1-week trailing moving window.  

This communication is for professional/institutional investors only and must not be relied upon by retail investors.  Any reproduction/redistribution of this information is prohibited.

This material is published for informational purposes only and is neither an offer to enter into, or a term or condition of any business or  agreement with the recipient or any other party, nor is it a solicitation for any services, securities, or funds herein, nor is it intended to provide investment, tax, or legal advice. If this material refers to funds, investments made therein are subject to the relevant fund documents. This material is not intended for distribution to persons or in jurisdictions where prohibited. No representation is made that any of the services, securities, or funds herein are suitable for any particular investor, and therefore, any prospective investor should consult their financial or other advisors about the appropriateness thereof. No representation or warranty is given as to the accuracy or completeness of this material. Investments may decrease in value and that past or backtested performance is no guide to future performance. Forward-looking or simulated data or information herein are subject to inherent limitations and are based upon assumptions that may not materialize, and may vary significantly from actual results. Investment models, research, and risk controls described  herein do not guarantee against loss of principal or that any investment objectives shown herein will be achieved. The data, projections, forecasts, anticipations, hypotheses and/or opinions herein are subjective, and are not necessarily used or followed by the firm or its affiliates who may act based on their own opinions and as independent departments or entities within the organization. This information is always subject to change and all rights are reserved thereof. Performance shown, unless otherwise stated, is gross of management fees. An investor’s actual return will be reduced by management fees and other expenses the investor may incur.

The firm seeks to achieve its clients’ investment objectives primarily through reliance on the modelling of proprietary and 3rd party financial and non-financial data, information, and considerations, the sources, weights, and implementation of which may be subject to change and/or the discretion of the firm regardless of whether described herein or elsewhere. Although many of its investment approaches are driven by bottom-up stock selection akin to that of a traditional fundamental investor, the firm seeks to achieve its clients’ investment objectives primarily in reliance on analytical models. The goal of the firm’s systematic approach is not to replicate a perfect “model” portfolio; instead, like other long-term, fundamentally oriented investors, it seeks to create portfolios possessing ex ante those fundamental and statistically important characteristics reflecting our investment beliefs. The firm’s ability to implement its investment objectives depends on various considerations such as the models’ economic, analytical and mathematical underpinnings, the accurate encapsulation of those principles in a complex computational (including software code) environment, the quality of the models’ data inputs, changes in market conditions, and the successful expression of the models' views into the investment portfolio construction process. Many of these have subjective elements that present the possibility of human error. While the investment process principally relies on models, the firm’s process also incorporates the investment judgment of its portfolio managers who may exercise discretion in attempting to capture the intent of the models, particularly in changing market conditions. The firm’s success in implementing its investment objectives may depend on the ability of portfolio managers and others to interpret and implement the signals generated by the models. The firm has established certain systematic rules and processes for monitoring client portfolios to ensure that they are managed in accordance with their investment objectives, but there is no guarantee that these rules or processes will effectively manage the risks associated with its investment process under all market conditions. While the firm employs controls designed to assure that our models are sound in their development and appropriately adapted, calibrated and configured, analytical error, software development errors, and implementation errors are an inherent risk of complex analytical models and quantitative investment management processes.  These errors may be extremely hard to detect, and some may go undetected for long periods of time or indefinitely. The firm’s controls, including our escalation policies, are designed to ensure that certain types of errors are subject to review once discovered. However, the effect of errors on our investment process and, where relevant, performance (which can be either positive or negative) may not be fully apparent even when discovered. When the firm discovers an investment process error in one of its models, it may in good faith and in accordance with its obligations, decide not to correct the error, to delay correction of an error, or develop other methodology to address the error, if not inconsistent with the client’s interests. Also, the firm generally will not disclose to affected clients investment process errors that are not the result of a contractual or regulatory breach, or that are non-compensable, unless it otherwise determines that information regarding the error is material to its clients.

If MSCI information appears herein, it may only be used for your internal use, it may not be reproduced or re-disseminated in any form, and it may not be used as a basis for, or a component of, any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information.  MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the “MSCI Parties”) expressly disclaims all warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to this information.  Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages. (www.mscibarra.com).

Certain ESG data provided by and/or calculated using Trucost data. Trucost reserves all intellectual and other proprietary rights in Trucost data.

Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office: 7 Newgate Street, London EC1A 7NX.

©2020 AXA Investment Managers. All rights reserved.

For Australian investors: AXA Investment Managers Asia (Singapore) Ltd (ARBN 115203622) is exempt from the requirement to hold an Australian Financial Services License and is regulated by the Monetary Authority of Singapore under Singaporean laws, which differ from Australian laws. AXA IM offers financial services in Australia only to residents who are “wholesale clients" within the meaning of Corporations Act 2001 (Cth).

For European investors: AXA Investment Managers UK Ltd is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Registered in England and Wales No. 01431068.  Registered Office: 7 Newgate Street, London EC1A 7NX. This material is intended for the use of persons meeting the MiFID client classification of Professional Clients or Eligible Counterparties and is not approved for communication to retail customers in any territory. The financial instruments used carry inherent risks which are unavoidable such as Market Risk, Credit Risk, Liquidity Risk and other risks. These risks are described in detail in our Risk Warnings document which is available upon request.

For Hong Kong investors: The authorisation of any fund by the Securities and Futures Commission in Hong Kong (“SFC”) does not imply official approval or recommendation. SFC authorization of a fund is not a recommendation or endorsement of a fund nor does it guarantee the commercial merits of a fund or its performance. It does not mean the fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. Where any of the Funds is not authorized by the SFC, the information contained herein in connection with such unauthorized Fund is solely for the use of professional investors in Hong Kong. Materials exempted from authorization by the SFC have not been reviewed by the SFC

For Japanese Clients: AXA INVESTMENT MANAGERS JAPAN LTD., whose registered office and principal place of business is at NBF Platinum Tower 14F 1-17-3 Shirokane, Minato-ku, Tokyo 108-0072, Japan, which is registered with the Financial Services Agency of Japan under the number KANTOZAIMUKYOKUCHO (KINSHO) 16, and is a member of Japan Securities Dealers Association, Type II Financial Instrument Firms Association, Investment Trust Association of Japan and Japan Investment Advisers Association to carry out the regulated activity of Financial Instrument Business under the Financial Instrument Exchange Law of Japan. In Japan, none of the funds mentioned in this document are registered under the Financial Instrument Exchange Law of Japan or Act on Investment Trusts and Investment Corporations. This document is purely for the information purpose for use by Qualified Institutional Investors defined by the Financial Instrument Exchange Law of Japan.

For Korean investors: In Korea, AXA Investment Managers Asia (Singapore) Ltd is a registered Cross Border Investment Advisor/Discretionary Investment Management Company under the Financial Investment Services and Capital Markets Act (the “Act”). The activities referenced under the Act are 5-2-2 Investment Advisory Business and 6-2-2 Discretionary Investment Management Business, respectively.  Its financial services are available in Korea only to Professional Investors within the meaning of Article 10 of Enforcement Decree of the Financial Investment Services and Capital Markets Act.

To the extent that any fund is mentioned in this document, neither the fund nor AXA IM Asia is making any representation with respect to the eligibility of any recipients of this document to acquire the units/shares in the fund under the laws of Korea, including but without limitation the Foreign Exchange Transaction Act and Regulations thereunder. The units/shares have not been registered under the Financial Investment Services and Capital Markets Act of Korea, and none of the units/shares may be offered, sold or delivered, or offered or sold to any person for re-offering or resale, directly or indirectly, in Korea or to any resident of Korea except pursuant to applicable laws and regulations of Korea.

For Singapore investors: In Singapore, this document is issued by AXA Investment Managers Asia (Singapore) Ltd. (Registration No. 199001714W) and is intended for the use of Institutional Investors only as defined in Section 4A of the Securities and Futures Act (Cap. 289) and must not be relied upon by retail investors. Circulation must be restricted accordingly.

For Swiss Investors: For Switzerland this information is intended exclusively for Qualified Investors according to Swiss law. Circulation must be restricted accordingly. The Swiss representative for the Irish-domiciled open-ended Unit Trust AXA Rosenberg Equity Alpha Trust, is First Independent Fund Services Ltd, Klausstrasse 33, CH-8008 Zurich. The Swiss paying agent is Credit Suisse, Paradeplatz 8, CH-8001 Zurich. The current prospectus, the Key Investor Information Document (the ‘KIID’) as well as the annual and semi-annual reports can be obtained free of charge from the Swiss representative. In respect of the units distributed in and from Switzerland, the place of jurisdiction is Zurich, Switzerland.
For Taiwan investors: The offer, distribution, sale or re-sale of fund units/shares in Taiwan requires approval from and/or registration with Taiwanese regulatory authorities. To the extent that any units/shares of the Funds are not so licensed or registered, such units/shares are made available in Taiwan on a private placement basis only to banks, bills houses, trust enterprises, financial holding companies and other qualified entities or institutions (collectively, “Qualified Institutions”) and other entities and individuals meeting specific criteria (“Other Qualified Investors”) pursuant to the private placement provisions of the Rules Governing Offshore Funds. No other offer or sale of such units/shares in Taiwan is permitted. Taiwanese purchasers of such units/shares may not sell or otherwise dispose of their holdings except by redemption, transfer to a Qualified Institution or Other Qualified Investor, transfer by operation of law or other means approved by the Taiwan Financial Supervisory Commission.
For Thailand investors: Nothing in this document shall constitute in any manner whatsoever a proposal to make available, offer for subscription or purchase or to issue an invitation to purchase or subscribe for any securities in Thailand or a proposal to implement any of the foregoing in Thailand nor has this document been approved by or registered with the Securities and Exchange Commission of Thailand (“SEC”). No person receiving a copy of this document may treat the same as constituting an invitation or offer to him in Thailand and such person shall not distribute or make available this document in Thailand. The issuer of this document shall not be liable in any manner whatsoever in the event this document is distributed or made available to any person in Thailand receiving a copy of this document. Since no application for approval has been or will be made to the SEC for the offering of the securities, or for the registration of this document, the securities shall not be offered for subscription or purchased or made available, whether directly or indirectly, in Thailand. It is the sole responsibility of recipients wishing to take any action upon this document to satisfy themselves as to the full observance of the laws of Thailand, to comply with all relevant government and regulatory approvals, and to comply with all applicable laws, including but not limited to exchange control laws.